Precision Oncology
Hospital in Bangalore

Precision Oncology uses information about a tumour’s genetic, molecular and biological characteristics to help doctors select cancer treatments suited to an individual patient.

Instead of considering only where a cancer started, this approach also considers how the tumour behaves and which molecular changes may be driving its growth. At Sparsh Hospital, precision oncology is supported by advanced cancer diagnostics, imaging, biopsy-guided evaluation and personalised treatment planning.

What is Precision Oncology?

Precision Oncology is an approach to cancer care that uses information about a tumour’s molecular and genetic characteristics to guide treatment decisions. Testing may identify mutations, biomarkers or other features that help doctors understand how the tumour behaves.

The results may help determine whether a patient could benefit from targeted therapy, immunotherapy or another treatment. Precision oncology does not replace conventional cancer treatment; it helps personalise treatment when relevant molecular findings are available.

When is Precision Oncology recommended?

Precision oncology may be considered when molecular or biomarker information could influence treatment decisions. It can be particularly relevant in selected advanced, metastatic, recurrent or treatment-resistant cancers, as well as some rare tumours.

Doctors may recommend molecular testing when a cancer has characteristics for which targeted treatments are available or when results could identify an appropriate clinical trial. The decision depends on the cancer type, stage, previous treatments and overall health.

What tests are used in Precision Oncology?

Precision oncology may involve different forms of molecular and biomarker testing. Depending on the cancer, doctors may recommend:

• Tumour tissue testing
• Immunohistochemistry
• Molecular or genetic testing
• Next-generation sequencing in selected cases
• Biomarker testing
• Testing for specific gene mutations or other alterations

Some tests analyse changes acquired by tumour cells, while other genetic tests may evaluate inherited changes when a hereditary cancer syndrome is suspected. The appropriate test depends on the cancer and the clinical question.

How does Precision Oncology work?

Precision oncology generally begins with a confirmed cancer diagnosis and an assessment of the patient’s history, imaging and pathology. If molecular testing is appropriate, a tissue or other suitable sample may be analysed for genetic or molecular characteristics.

The results are interpreted alongside the cancer type, stage, previous treatment and overall health. If an actionable alteration is identified, the oncology team may consider a treatment that targets it. If no suitable target is found, another evidence-based treatment may still be appropriate.

What treatments can Precision Oncology help guide?

Precision oncology can help identify treatment options for selected patients based on tumour characteristics. These may include:

• Targeted therapy designed to act on specific molecular pathways
• Immunotherapy for cancers with relevant biomarkers
• Chemotherapy when appropriate
• Clinical trials involving biomarker-selected treatments

Not every tumour has an actionable molecular alteration, and a mutation does not automatically mean that a particular medicine will be effective. Treatment decisions require specialist interpretation of test results and the patient’s complete clinical picture.

What are the benefits of Precision Oncology?

The main benefit of precision oncology is the ability to make treatment decisions using detailed information about a tumour. In selected patients, this may help identify therapies that would not be considered from the cancer’s location alone.

For some advanced or rare cancers, molecular testing may identify targeted treatment options or clinical trials. However, benefits depend on the cancer, the test performed and whether an actionable finding is identified.

How does advanced technology support Precision Oncology at Sparsh?

Sparsh Hospital supports precision oncology with advanced cancer diagnostic and treatment technologies. PET-CT, MRI, and CT help specialists evaluate tumour location, extent, and treatment response, while biopsy-guided diagnosis provides tissue for detailed assessment.

The oncology team also uses precision oncology approaches, targeted cancer therapy, image-guided radiation planning and personalised treatment strategies based on tumour biology and patient condition.

How does multidisciplinary care support Precision Oncology?

Precision oncology often requires collaboration between medical oncologists, pathologists, radiologists, surgeons, radiation oncologists and other specialists. Molecular results need to be interpreted alongside pathology, imaging and clinical findings.

A multidisciplinary approach can help determine whether a molecular alteration is clinically meaningful and how a targeted treatment fits into the patient’s overall care plan.

Where can you get Precision Oncology care in Bangalore?

Patients searching for a Precision Oncology hospital near home can consider Sparsh Hospital for specialised oncology evaluation and treatment planning in Bangalore. For those looking for a Precision Oncology hospital in Bangalore, the right specialist and service may vary by cancer type and treatment needs, so patients should confirm availability when scheduling an appointment.

Conclusion

Precision Oncology brings tumour biology, molecular information and clinical assessment together to support more personalised cancer treatment. It may help identify targeted therapies or other treatment options for selected patients when specific biomarkers or molecular alterations are present.

At Sparsh Hospital, precision oncology is supported by advanced imaging, biopsy-guided diagnosis, targeted cancer therapy, image-guided radiation planning and personalised treatment strategies. The oncology team evaluates each patient’s condition to determine the most appropriate approach.